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EDITORIAL
As most of our readers and authors will know, in 2005 Nucleic Acids Research became one of the ﬁrst established journals
to move from a subscription-based publishing model to author-pays open access. This means that all articles published in
the journal are freely available online to everybody, ensuring wide dissemination and high usage.
When we embarked on this initiative we believed that it would not be possible to replace the journal’s subscription
income overnight with income from author charges, and so we aimed to make the transition to full open access via a
mixed model, funded by a combination of author charges, institutional memberships, and print subscriptions. Thanks to
the support of NAR’s community, we are very pleased to say that the model has been a success so far. Submissions have
remained stable and the results of our ongoing author surveys suggest that the majority of authors are very happy with the
service NAR provides.
Income from sales of the NAR print subscription has helped to subsidize author charges in this transitional period. As
was expected, print subscriptions have declined under the open access model, and so each year we have needed to increase
the author open access charges to compensate for this decline. Based on projections for the 2008 volume we have decided
to increase the author open access charges in 2008 by 10% to the following:
Author charge 2007 2008
Non-member OA charge £1250/$2370/E1870 £1370/$2670/E2050
Member OA charge £625/$1185/E935 £685/$1335/E1025
Excess page charge £90/$170/E135 £100/$195/E150
Discounts and waivers will continue to be available for authors in developing countries and we also consider waivers in
other cases of genuine ﬁnancial hardship.
Our research into the average author charges paid for other journals in the ﬁeld suggests that NAR remains competitive
under the open access model (when, for example, colour charges, page charges, charges for electronic oﬀprints/PDFs, and
optional or mandatory open access charges are taken into account). We will continue to strive to ensure that NAR
remains attractive and accessible to its authors.
Along with immediate free access online, a beneﬁt of NAR’s open access model is that authors are able to deposit the
ﬁnal version of their article in institutional and subject repositories. This allows, for example, NIH, UK MRC and
Wellcome Trust grantees to comply with the policies of their funders. The entire content of NAR is automatically
deposited by Oxford Journals in the PubMed Central repositories upon publication, removing the need for NAR authors
to take this step. Under the journal’s Creative Commons Attribution Non-Commercial License (http://creativecommons.
org/licenses/by-nc/2.0/uk/), all users are also free to re-use NAR content for non-commercial purposes, providing another
beneﬁt to the community.
We very much hope that our authors and readers will continue to support NAR and as always welcome comments and
suggestions that will help shape the journal in the future.
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